Literature DB >> 28641921

Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort.

Jin Li1, Qiushi Zhang2, Feng Chen1, Xianglian Meng1, Wenjie Liu1, Dandan Chen2, Jingwen Yan3, Sungeun Kim4, Lei Wang1, Weixing Feng1, Andrew J Saykin4, Hong Liang5, Li Shen6.   

Abstract

The pathogenic relevance in Alzheimer's disease (AD) presents a decrease of cerebrospinal fluid amyloid-ß42 (Aß42) burden and an increase in cerebrospinal fluid total tau (T-tau) levels. In this work, we performed genome-wide association study (GWAS) and genome-wide interaction study of T-tau/Aß42 ratio as an AD imaging quantitative trait on 843 subjects and 563,980 single-nucleotide polymorphisms (SNPs) in ADNI cohort. We aim to identify not only SNPs with significant main effects but also SNPs with interaction effects to help explain "missing heritability". Linear regression method was used to detect SNP-SNP interactions among SNPs with uncorrected p-value ≤0.01 from the GWAS. Age, gender, and diagnosis were considered as covariates in both studies. The GWAS results replicated the previously reported AD-related genes APOE, APOC1, and TOMM40, as well as identified 14 novel genes, which showed genome-wide statistical significance. Genome-wide interaction study revealed 7 pairs of SNPs meeting the cell-size criteria and with bonferroni-corrected p-value ≤0.05. As we expect, these interaction pairs all had marginal main effects but explained a relatively high-level variance of T-tau/Aß42, demonstrating their potential association with AD pathology.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADNI; Amyloid-ß(42) (Aß(42)); Cerebrospinal fluid (CSF); GWIS; T-tau/Aß(42) ratio; Total tau (T-tau)

Mesh:

Substances:

Year:  2017        PMID: 28641921      PMCID: PMC5869719          DOI: 10.1016/j.neurobiolaging.2017.05.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   5.133


  41 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  INTERSNP: genome-wide interaction analysis guided by a priori information.

Authors:  Christine Herold; Michael Steffens; Felix F Brockschmidt; Max P Baur; Tim Becker
Journal:  Bioinformatics       Date:  2009-10-16       Impact factor: 6.937

4.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Authors:  Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2007-01-08

5.  Gelsolin regulates proliferation, apoptosis, migration and invasion in human oral carcinoma cells.

Authors:  Runzhi Deng; Jing Hao; Wei Han; Yanhong Ni; Xiaofeng Huang; Qingang Hu
Journal:  Oncol Lett       Date:  2015-03-02       Impact factor: 2.967

6.  Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

Authors:  E R Peskind; W S Griffin; K T Akama; M A Raskind; L J Van Eldik
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

7.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression.

Authors:  Omid Kohannim; Derrek P Hibar; Jason L Stein; Neda Jahanshad; Xue Hua; Priya Rajagopalan; Arthur W Toga; Clifford R Jack; Michael W Weiner; Greig I de Zubicaray; Katie L McMahon; Narelle K Hansell; Nicholas G Martin; Margaret J Wright; Paul M Thompson
Journal:  Front Neurosci       Date:  2012-08-06       Impact factor: 4.677

9.  GWIS--model-free, fast and exhaustive search for epistatic interactions in case-control GWAS.

Authors:  Benjamin Goudey; David Rawlinson; Qiao Wang; Fan Shi; Herman Ferra; Richard M Campbell; Linda Stern; Michael T Inouye; Cheng Soon Ong; Adam Kowalczyk
Journal:  BMC Genomics       Date:  2013-05-28       Impact factor: 3.969

10.  Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.

Authors:  Bradford C Dickerson; David A Wolk
Journal:  Front Aging Neurosci       Date:  2013-10-11       Impact factor: 5.750

View more
  7 in total

1.  Morbigenous brain region and gene detection with a genetically evolved random neural network cluster approach in late mild cognitive impairment.

Authors:  Xia-An Bi; Yingchao Liu; Yiming Xie; Xi Hu; Qinghua Jiang
Journal:  Bioinformatics       Date:  2020-04-15       Impact factor: 6.937

Review 2.  Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress.

Authors:  Illana Gozes
Journal:  EPMA J       Date:  2017-09-04       Impact factor: 6.543

3.  Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.

Authors:  Changan Liu; Jacqueline Chyr; Weiling Zhao; Yungang Xu; Zhiwei Ji; Hua Tan; Claudio Soto; Xiaobo Zhou
Journal:  Front Genet       Date:  2018-09-24       Impact factor: 4.599

4.  Quantitative Trait Module-Based Genetic Analysis of Alzheimer's Disease.

Authors:  Shaoxun Yuan; Haitao Li; Jianming Xie; Xiao Sun
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

5.  Benchmarking machine learning models for late-onset alzheimer's disease prediction from genomic data.

Authors:  Javier De Velasco Oriol; Edgar E Vallejo; Karol Estrada; José Gerardo Taméz Peña; The Alzheimer's Disease Neuroimaging Initiative
Journal:  BMC Bioinformatics       Date:  2019-12-16       Impact factor: 3.169

6.  Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review.

Authors:  David Vogrinc; Katja Goričar; Vita Dolžan
Journal:  Front Aging Neurosci       Date:  2021-03-18       Impact factor: 5.750

7.  Predictive classification of Alzheimer's disease using brain imaging and genetic data.

Authors:  Jinhua Sheng; Yu Xin; Qiao Zhang; Luyun Wang; Ze Yang; Jie Yin
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.